Clinical Trial

Perspectives on Antibiotics and Tracking Symptoms in Children

Study acronym: PATSy
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 22, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The study will assess families' perspectives and decision-making regarding the duration of oral antibiotic courses prescribed to children (4-17 years) who present with uncomplicated bacterial infections at the Royal Children's Hospital (RCH) Emergency Department (ED). The study will involve (i) children discharged from ED on oral antibiotics and (ii) children transferred to Hospital-in-the-Home (HITH) on IV antibiotics who then switch to oral antibiotics. In addition, the study will assess how feasible and acceptable it is to track children's symptoms via the Garmin Smartwatch and the WeGuide platform (WeGuide is a patient engagement software platform that allows for enrolment, consent, and data collection \[via questionnaires/surveys and from the Garmin Smartwatches\] through a singular platform).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-22.
Status change: Not Yet Recruiting → Recruiting 2025-09-17
Trial Details
NCT Number NCT07093749
Lead Sponsor Murdoch Childrens Research Institute
Collaborators: Royal Children's Hospital
Conditions Urinary Tract Infection, Cellulitis, Impetigo, Pharyngitis, Tonsillitis, Respiratory Tract Infections, Otitis Media
Enrollment 300 participants
Start Date 2025-09-16
Primary Completion 2026-06 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-09-22